Organization Profile

You just read:

Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of "Remdesivir" in 127 Countries, Including India, for COVID-19

News provided by

Hetero

May 13, 2020, 12:54 ET